Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study-Reference-Cited by-同舟云学术

Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study

Published:2023-08-01 Issue:10 Volume:28 Page:1411-1420
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Baba Tsukasa^ORCID,Koshiyama Masafumi,Kagabu Masahiro,Mikami Yoshiki,Minamiguchi Sachiko,Moritani Suzuko,Ishikawa Mitsuya,Okamoto Aikou,Terao Yasuhisa,Nakanishi Toru,Katabuchi Hidetaka,Tokunaga Hideki,Satoh Toyomi,Konishi Ikuo,Yaegashi Nobuo

Funder

Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-023-02393-z.pdf

Reference18 articles.

1. Japan Society of Gynecologic Oncology, ed. Ovarian cancer treatment guidelines 2010 (in Japanese). Kanehara & Co. Ltd, Tokyo. 97–106.

2. Longacre TA, McKenney JK, Tazelaar HD et al (2005) Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up. Am J Surg Pathol 29:707–723. PMID: 15897738

3. Prat J, De Nictolis M (2002) Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 26:1111–1128

4. Seidman JD, Kurman RJ (2000) Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 31:539–557

5. Kane A, Uzan C, Rey A et al (2009) Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants. Oncologist 14:591–600